SuperworthViking Therapeutics market cap VKTX
Share price times shares outstanding: what the whole company sells for, since 2015.
- Today, Oct 23, 2026
- $2.8B
- Highest close in our data
- $8.7B
- Oct 2024
Viking Therapeutics is worth $2.8B at the close on Oct 23, 2026, at $24.40 a share.
That is down 27% over the last year and up 525% over five years.
Its highest close in our data was $8.7B in Oct 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.8B | $2.8B | $4.5B | −32% |
| 2025 | $4.2B | $2.5B | $4.8B | −8% |
| 2024 | $4.6B | $1.8B | $8.7B | +146% |
| 2023 | $1.9B | $647.3M | $2.4B | +158% |
| 2022 | $720.9M | $172.5M | $720.9M | +100% |
| 2021 | $359.9M | $359.9M | $705.4M | −12% |
| 2020 | $410.7M | $304M | $577.1M | −32% |
| 2019 | $602M | $462.1M | $765.2M | +11% |
| 2018 | $541M | $132.5M | $1.1B | +368% |
| 2017 | $115.7M | $23.6M | $116.3M | +382% |
| 2016 | $24M | $11.7M | $28.4M | −27% |
| 2015 | $33M | $19.6M | $75M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Viking Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| VKTXViking Therapeutics | $2.8B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| HRMYHarmony Biosciences | $2.1B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| Peer median | $2.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Viking Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.